130 related articles for article (PubMed ID: 37800294)
1. A Case of Immune Thrombocytopenia Occurring after Radiotherapy plus Atezolizumab Treatment for Bladder Cancer.
Sekiguchi Y; Nishimura Y; Kanda H; Kawamura M; Kobayashi K; Mitani K; Kurashina R; Ikeda R; Inoue M; Matsuoka Y; Kageyama Y; Akaba Y; Kobayashi H
Gan To Kagaku Ryoho; 2023 Sep; 50(9):985-992. PubMed ID: 37800294
[TBL] [Abstract][Full Text] [Related]
2. Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia.
Yılmaz A; Mirili C; Bilici M; Tekin SB
J Oncol Pharm Pract; 2020 Oct; 26(7):1791-1794. PubMed ID: 32237958
[TBL] [Abstract][Full Text] [Related]
3. Evans' syndrome induced by atezolizumab plus bevacizumab combination therapy in advanced hepatocellular carcinoma.
Fukushima M; Tajima K; Sasaki R; Nakao Y; Takahashi K; Ozawa E; Miuma S; Kato T; Miyaaki H; Nakao K
Clin J Gastroenterol; 2023 Jun; 16(3):402-406. PubMed ID: 36746879
[TBL] [Abstract][Full Text] [Related]
4. Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer.
Marcq G; Souhami L; Cury FL; Salimi A; Aprikian A; Tanguay S; Vanhuyse M; Rajan R; Brimo F; Mansure JJ; Kassouf W
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):738-741. PubMed ID: 33421558
[TBL] [Abstract][Full Text] [Related]
5. Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.
Molinero L; Li Y; Chang CW; Maund S; Berg M; Harrison J; Fassò M; O'Hear C; Hegde P; Emens LA
J Immunother Cancer; 2019 Oct; 7(1):274. PubMed ID: 31647026
[TBL] [Abstract][Full Text] [Related]
6. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.
Bayraktar S; Eileen B; Shariatmadar S; Lian E
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444
[TBL] [Abstract][Full Text] [Related]
7. Mean Platelet Volume, Platelet Distribution Width, and Platelet Count, in Connection with Immune Thrombocytopenic Purpura and Essential Thrombocytopenia.
Lee E; Kim M; Jeon K; Lee J; Lee JS; Kim HS; Kang HJ; Lee YK
Lab Med; 2019 Jul; 50(3):279-285. PubMed ID: 30726936
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic Thrombocytopenia Purpura After Pembrolizumab Treatment Against Locally Recurrent Bladder Cancer : A Case Report].
Hattori Y; Kato M; Imamura T; Inaba S; Terabe T; Kato M; Higashi S; Sasaki T; Masui S; Yoshio Y; Nishikawa K; Uchida K; Inoue T
Hinyokika Kiyo; 2023 Sep; 69(9):255-258. PubMed ID: 37794676
[TBL] [Abstract][Full Text] [Related]
9. Graves' disease-induced immune thrombocytopenic purpura in an African female: a case report.
Agyapong KO; Folson AA; Fiador K; Kootin-Sanwu C; Tufuor M; Bampoh SA; Fiscian H; Wonkyi R
J Med Case Rep; 2023 Apr; 17(1):122. PubMed ID: 37016396
[TBL] [Abstract][Full Text] [Related]
10. [Gabexate mesilate induced recovery from thrombocytopenia in a patient with acute ITP].
Toyozumi H; Ikeda Y
Rinsho Ketsueki; 1996 Jul; 37(7):624-9. PubMed ID: 8779783
[TBL] [Abstract][Full Text] [Related]
11. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
Al-Husban N; Al-Kuran O
J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
[TBL] [Abstract][Full Text] [Related]
12. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review.
Bancheno WM; Adidam SR; Melaku MA
Medicine (Baltimore); 2022 Jul; 101(29):e29616. PubMed ID: 35866784
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D
J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462
[TBL] [Abstract][Full Text] [Related]
14. A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial.
Gonzalez Martin A; Sanchez Lorenzo L; Colombo N; dePont Christensen R; Heitz F; Meirovitz M; Selle F; van Gorp T; Alvarez N; Sanchez J; Marqués C
Int J Gynecol Cancer; 2021 Apr; 31(4):617-622. PubMed ID: 33318079
[TBL] [Abstract][Full Text] [Related]
15. [Development of acquired hemophilia A during maintenance therapy for immune thrombocytopenia].
Ogawa Y; Yanagisawa K; Ishizaki T; Naito C; Mihara M; Handa H; Shizuka R; Inoue M; Naito S; Ieko M; Ichinose A; Nojima Y
Rinsho Ketsueki; 2016 Apr; 57(4):456-60. PubMed ID: 27169450
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy.
Tamanoi D; Saruwatari K; Imamura K; Sato R; Jodai T; Hamada S; Tomita Y; Saeki S; Ueno S; Yonemura Y; Ichiyasu H; Sakagami T
Intern Med; 2022 Jun; 61(11):1731-1734. PubMed ID: 34776479
[TBL] [Abstract][Full Text] [Related]
17. Resection of bulky chromophobe renal cell carcinoma resolved severe idiopathic thrombocytopenic purpura: A case report.
Maekawa S; Nagata M; Watanabe H; Nozaki K; Takahashi A; Minowada S; Homma Y
Int J Urol; 2015 Dec; 22(12):1167-9. PubMed ID: 26354444
[TBL] [Abstract][Full Text] [Related]
18. Immune thrombocytopenia in an elderly patient treated successfully by pulse therapy with cyclophosphamide.
Ikeda K; Shichishima T; Yui T; Sakai K; Ohtake A; Ishibashi T; Noji H; Maruyama Y
Fukushima J Med Sci; 2001 Jun; 47(1):33-8. PubMed ID: 11764416
[TBL] [Abstract][Full Text] [Related]
19. Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report.
Horino T; Sasaoka A; Takao T; Taguchi T; Maruyama H; Ito H; Takemoto S; Taguchi H; Hashimoto K
Clin Rheumatol; 2005 Nov; 24(6):641-4. PubMed ID: 15864685
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
Sun L; Wang J; Shao L; Yuan C; Zhao H; Li D; Wang Z; Han P; Yu Y; Xu M; Zhao H; Qiu J; Zhou H; Liu X; Hou Y; Peng J; Hou M
Lancet Haematol; 2021 Apr; 8(4):e289-e298. PubMed ID: 33770484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
